Jerzy Pieczykolan
Jerzy Pieczykolan publishes mostly in Molecular Biology, Oncology and Cancer Research, on topics such as Cancer Research and Treatments, Cell death mechanisms and regulation and Fibroblast Growth Factor Research.
- World rank
- #7,115,242 of 7,710,434 ranked researchers
- Rank in Poland
- #83,748 of 100,960
- Works
- 55
- Citations
- 381
- Citations per work
- 6.9
What does Jerzy Pieczykolan research?
Jerzy Pieczykolan's work is mostly in Biochemistry, Genetics and Molecular Biology (40%), Medicine (10%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences2545.5%
- Everything else2444.0%
- Health Sciences610.5%
- Medicine610.5%
- 1Molecular Biology27% of their works
- 2Oncology6% of their works
- 3Cancer Research6% of their works
- 4Biotechnology6% of their works
- 5Immunology6% of their works
- 6Pulmonary and Respiratory Medicine4% of their works
Research topics
Which keywords describe Jerzy Pieczykolan's research?
The keywords of their largest research topics: Bacterial Therapy, Tumor Targeting, Apoptosis, Cell Death, FGF21, Fibroblast Growth Factor, cAMP Signaling and Cardiovascular Outcomes.
- apoptotic cells
- cAMP Signaling
- Type 2 Diabetes
- G-Protein-Coupled Receptors
- Crystal Structure
- Fibroblast Growth Factor
- Cell Death
- Tumor Targeting
- Bacterial Therapy
- Apoptosis
- FGF21
- Cardiovascular Outcomes
- Cyclic Nucleotide Phosphodiesterases
- HIF-1
- Warburg Effect
- CD47
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 16 words, with their numbers
- Bacterial Therapy91 topic
- Tumor Targeting91 topic
- Apoptosis61 topic
- Cell Death61 topic
- FGF2161 topic
- Fibroblast Growth Factor61 topic
- Cardiovascular Outcomes51 topic
- Crystal Structure51 topic
- Cyclic Nucleotide Phosphodiesterases51 topic
- G-Protein-Coupled Receptors51 topic
- HIF-151 topic
- Type 2 Diabetes51 topic
- Warburg Effect51 topic
- cAMP Signaling51 topic
- CD4741 topic
- apoptotic cells41 topic
Where does Jerzy Pieczykolan work?
Jerzy Pieczykolan's main affiliation in the publication record is Celon Pharma (Poland), Poland.
How many publications and citations does Jerzy Pieczykolan have?
OpenAlex counts 55 works and 381 citations for Jerzy Pieczykolan, an h-index of 12, ranking #7,115,242 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jerzy Pieczykolan. Posts are plain text and can be reported.